Prospera Financial Services’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,955
Closed -$30.7K 1146
2024
Q3
$30.7K Buy
2,955
+207
+8% +$3.44K ﹤0.01% 1107
2024
Q2
$54.1K Buy
2,748
+673
+32% +$13.5K ﹤0.01% 1111
2024
Q1
$53.1K Buy
2,075
+1,440
+227% +$36.9K ﹤0.01% 1076
2023
Q4
$17.5K Buy
+635
New +$38.7K ﹤0.01% 1043
2022
Q3
Sell
-23
Closed -$2K 917
2022
Q2
$2K Buy
23
+3
+15% +$233 ﹤0.01% 1536
2022
Q1
$2K Buy
+20
New +$2.64K ﹤0.01% 2455

Other funds holding BLUE

Prospera Financial Services's BLUE Position: Q4 2024 in Review

Prospera Financial Services sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 2,955 shares — an estimated $30.7K sold.

Prospera Financial Services first reported a position in BLUE in Q1 2022 and held it in 6 quarters. The position peaked at $54.1K in Q2 2024. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Prospera Financial Services reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Prospera Financial Services sold 2,955 bluebird bio shares in Q4 2024, an estimated $30.7K.
  • Prospera Financial Services first reported a position in bluebird bio in Q1 2022 and held it in 6 quarters.
  • Prospera Financial Services's bluebird bio position peaked at $54.1K in Q2 2024.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Prospera Financial Services's 13F filing for Q4 2024, filed 13 Feb 2025.